Application Note: RP Analyses of Monoclonal Antibodies Using High Temperatures
28 June 2019

In this application note, YMC illustrates how to achieve robust chromatographic results for two commercially available MAbs: Adalimumab (e.g. Humira®) and Bevacizumab (Avastin®)  with the YMC-Triart Bio C4.